ZTS · NYSE · Drug Manufacturers - Specialty & Generic

Zoetis

Develops medicines, vaccines, diagnostics and precision-health tools for pets and livestock.

$77.47
After-hours close+0.18 (+0.23%)
At close$77.29(+3.03%)

Breakdown13F · Form 4

Institutions 106.91%Insiders 0.07%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 419.23M · Float 418.38M · 99.8% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.39.43M9.41%13FAug 7, 2026
Vanguard Capital Management LLC26.03M6.21%13FAug 13, 2026
Vanguard Portfolio Management LLC23.86M5.69%13FAug 13, 2026
State Street Corp19.67M4.69%13FAug 7, 2026
State Farm Mutual Automobile Insurance Co15.89M3.79%13FAug 12, 2026

Institutions13F, as of Jun 30, 2026

1,485 holders · 448.20M shares · 177 new positions · 682 increased · 602 reduced · 356 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.39.43M9.41%+3.85MAug 7, 2026
Vanguard Capital Management LLC26.03M6.21%−44.9KAug 13, 2026
Vanguard Portfolio Management LLC23.86M5.69%−107.0KAug 13, 2026
State Street Corp19.67M4.69%+343.3KAug 7, 2026
State Farm Mutual Automobile Insurance Co15.89M3.79%0Aug 12, 2026
Geode Capital Management, LLC13.29M3.17%+1.94MAug 12, 2026
Wellington Management Group LLP9.42M2.25%−726.2KAug 14, 2026
Morgan Stanley8.88M2.12%−5.27MAug 13, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Vanguard Capital Management7.17%30.28M13GApr 30, 2026
Vanguard Portfolio Management5.70%24.07M13GApr 29, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Kristin C. Peckdirector, officer: Chief Executive Officer105.1K0.03%Feb 23, 2026
Paul Bisarodirector27.9K0.01%May 13, 2026
Michael B. Mccallisterdirector24.5K0.01%Jun 11, 2026
Wetteny Josephofficer: Chief Financial Officer22.1K0.01%Feb 23, 2026
Louise M. Parentdirector18.2K0.00%May 21, 2026
Roxanne Laganoofficer: Executive Vice President15.6K0.00%Feb 23, 2026
Frank A. Dameliodirector14.8K0.00%Aug 11, 2026
Willie M. Reeddirector12.9K0.00%Feb 23, 2026
Rimma Driscollofficer: Executive Vice President5.7K0.00%Feb 23, 2026
Robert W. Scullydirector5.6K0.00%May 23, 2025

25 people have not refiled in the last 18 months (25.47M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
May 13, 2026
Paul Bisarodirector
Purchase2,000$75.8827,862
May 13, 2026
Frank A. Dameliodirector
Purchase6,650$75.3921,458
May 11, 2026
Michael B. Mccallisterdirector
Purchase3,000$77.7624,524
Feb 17, 2026
Kristin C. Peckdirector, officer: Chief Executive Officer
Sale · 2 lots20,000$127.05101,337

CongressHouse and Senate disclosures

MemberTypeAmountOwnerTradedDisclosed
Rep. Ro Khanna · CA17Purchase$1,001 – $15,000Jul 7, 2026Aug 12, 2026
Rep. Byron Donalds · FL19Purchase$1,001 – $15,000Jun 9, 2026Jul 16, 2026
Rep. Charles J. "Chuck" Fleischmann · TN03Purchase$15,001 – $50,000JointJun 9, 2026Jul 13, 2026
Rep. Gilbert Cisneros · CA31Purchase$1,001 – $15,000Jun 16, 2026Jul 3, 2026
Rep. Ro Khanna · CA17Purchase$1,001 – $15,000May 1, 2026Jun 11, 2026